Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT05009953 · TERMINATED
Trial details
- NCT number
- NCT05009953
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-01-16
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.